Ionclinics

Ionclinics is a health sector company focused on the design, development, and commercialization of electromedical devices for neuromodulation. Their mission is to expand access to neuromodulation therapies for treating conditions affecting the central and peripheral nervous systems, including chronic pain, mental health disorders, neurological disorders, and musculoskeletal issues. The company offers innovative products such as the EPTE Bipolar System, EPTE Home, and EPTE System, which are designed for both invasive and non-invasive therapies. Their technologies include transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), and neuromuscular percutaneous stimulation (NMP), all supported by scientific research. Ionclinics emphasizes research and innovation, collaborating with medical and scientific teams to ensure their devices meet high standards and regulatory approvals. Operating internationally, Ionclinics serves health professionals in psychology, neurology, rehabilitation, and related fields. They also provide specialized training and courses to enhance the clinical application of their technologies, contributing to improved patient quality of life in chronic and psychiatric conditions.

• Employees 30
• Founded 2012